Ocugen
Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen is based in Pennsylvania.
Last updated on
About Ocugen
Founded
2013Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$190MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
MalvernState
PennsylvaniaCountry
United StatesOcugen
Find your buyer within Ocugen